Spine Tech and Orquest to combine technologies
This article was originally published in Clinica
Spine Tech is to file an IDE with the US FDA to evaluate its spinal fusion devices (BAK) with Orquest's resorbable bone grafting material (Healos). Orquest's product is a porous matrix of collagen impregnated with resorbable hydroxyapatite that provides a scaffold for bone formation. The two companies plan to evaluate the material with Spine-Tech's hollow, threaded titanium alloy cylinders, which can be implanted in the spaces between vertebrae in the lumbar spine. Currently, some 80 per cent of bone grafting procedures harvest the patient's own bone, causing pain and long, expensive hospital stays.